A 2017 study showed that IL-17A was involved in the pathophysiology of allergies by increasing the ability of IL-13 to activate signaling pathways such as intracellular signal transduction and activation of transcription factor 6 (STAT-6). The gene discussed is IL13; the disease is allergic disease.